Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Milan
Clinical trial register · Italy

Clinical Trials in Milan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS San Raffaele160 AstraZeneca137 Merck Sharp & Dohme LLC98 Hoffmann-La Roche80 Novartis Pharmaceuticals73
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Milan

2846 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Active, closed
TRILUMINATE Pivotal Trial
NCT03904147Tricuspid Regurgitation
Abbott Medical Devices
Not applicable
572
Milan
2019-08-21
Recruiting
Registry of Subjects at Risk of Pancreatic Cancer
NCT04095195Familial Pancreatic Cancer, BRCA1 Mutation, BRCA2 Mutation, Lynch Syndrome
Associazione Italiana per lo Studio del Pancreas
Observational
1,000
Rozzano, Peschiera del Garda, Milan, Verona
2019-08-20
Active, closed
BeOne Medicines
Phase 3
510
Alessandria, Bologna, Genova, Milan, Novara, Palermo, Pisa, Ravenna
2019-08-20
Active, closed
Sanofi
Observational
1,860
Terracina, Naples, Padua, Bari, Bologna, Brescia, Catania, Milan
2019-08-15
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Ascoli Piceno, Brescia, Catania, Florence, Milan, Monza, Novara, Roma
2019-08-15
Active, closed
Hoffmann-La Roche
Phase 1/2
498
Naples, Bergamo, Milan, Rozzano
2019-08-13
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Naples, Rome, Genoa, Milan, Pavia, Orbassano, Cefalù
2019-08-12
Active, closed
Bristol-Myers Squibb
Phase 3
839
Catania, Genova, Milan, Naples, Padova, Roma
2019-08-05
Active, closed
OncoVerity, Inc.
Phase 2
103
Bologna, Brescia, Meldola, Milan, Naples, Udine
2019-07-29
Active, closed
Novartis Pharmaceuticals
Phase 3
254
Genova, Milan, Verona, Naples
2019-07-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Roma, Orbassano, Vicenza, Arezzo, Catania, Milan, Naples, Pavia
2019-07-24
Active, closed
Screening and Multiple Intervention on Lung Epidemics
NCT03654105Inflammation, Smoking Cessation, Diet Modification, Physical Activity
DrugsCytisine·Acetylsalicylic acid
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2
2,000
Milan
2019-07-23
Active, closed
Amgen
Phase 3
457
Milan, Palermo, Pavia, Roma
2019-07-19
Active, closed
Tesaro, Inc.
Phase 3
785
Candiolo, Carpi MO, Lecce, Milan, Naples, Ponderano BI, Rome, Sassuolo
2019-07-18
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
197
Bergamo, Milan, Naples
2019-07-17
Active, closed
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
NCT04008797Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms
DrugsE7386·Doxorubicin·Lenvatinib·Paclitaxel
Eisai Inc.
Phase 1/2
301
Ancona, Milan, Rome
2019-07-11
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Aviano, Catania, Florence, Meldola, Milan, Parma, Ravenna, Reggio Emilia
2019-07-09
Active, closed
Novo Nordisk A/S
Phase 2
62
Florence, Genova, Milan, Roma
2019-07-04
Active, closed
Impact of Stress CT Myocardial Perfusion on Downstream Resources and Prognosis
NCT03976921Coronary Artery Disease, Myocardial Ischemia
Centro Cardiologico Monzino
Not applicable
2,000
Milan
2019-07-01
Active, closed
Fondazione EMN Italy Onlus
Phase 2
45
Ancona, Bari, Bergamo, Bologna, Brescia, Catania, Milan, Novara
2019-07-01
Recruiting
Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK
NCT04181970Soft-tissue Sarcoma, Gastrointestinal Stromal Tumors, Bone Sarcoma
Grupo Espanol de Investigacion en Sarcomas
Observational
5,000
Bologna, Milan
2019-06-30
Active, closed
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
NCT03960840Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia
DrugIbrutinib
Novartis Pharmaceuticals
Phase 1/2
217
Bergamo, Milan, Rozzano
2019-06-26
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Acquaviva delle Fonti, Arezzo, Brescia, Florence, Milan, Negrar, Pavia, Perugia
2019-06-24
Active, closed
Bristol-Myers Squibb
Phase 3
437
Brescia, Arezzo, Aviano (PN), Milan, Parma, Roma
2019-06-21
Recruiting
Istituto Auxologico Italiano
Observational
30
Milan
2019-06-18
Recruiting
Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms
NCT05748028Parkinson Disease, Multiple System Atrophy
Istituti Clinici Scientifici Maugeri SpA
Observational
280
Telese Terme, Lumezzane, Castel Goffredo, Mistretta, Veruno, Montescano, Milan, Pavia
2019-06-15
Recruiting
Population Health Research Institute
Phase 4
2,270
Milan, Alessandria, Palermo, Piacenza
2019-06-14
Active, closed
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
NCT03899792Medullary Thyroid Cancer, Infantile Myofibromatosis, Infantile Fibrosarcoma, Papillary Thyroid Cancer
DrugSelpercatinib
Eli Lilly and Company
Phase 1/2
36
Milan
2019-06-13
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Abano Terme, Acquaviva delle Fonti, Bassano del Grappa, Brescia, Chieti, Florence, Milan, Modena
2019-06-11
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
1,210
Milan
2019-06-06
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Bergamo, Bologna, Brescia, Florence, L’Aquila, Milan, Naples, Rome
2019-06-04
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
200
Milan
2019-06-01
Active, closed
Celgene
Phase 1/2
438
Bergamo, Bologna, Milan, Naples, Pavia
2019-05-20
Active, closed
IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
NCT03503409Myelodysplastic Syndromes, Acute Myeloid Leukemia
DrugIvosidenib
Groupe Francophone des Myelodysplasies
Phase 2
68
Alessandria, Ancona, Bologna, Brescia, Florence, Genova, Lecce, Milan
2019-05-14
Recruiting
Virtual Reality Rehabilitation in Neck Pain Subjects
NCT03987334Neck Pain, Chronic Pain, Whiplash
IRCCS San Raffaele
Not applicable
72
Milan
2019-05-09
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Milan, Padova, Florence, Genova, Treviso
2019-05-09
Active, closed
Inspiris Resilia Durability Registry
NCT03666741Aortic Valve Stenosis
Institut für Pharmakologie und Präventive Medizin
Observational
400
Florence, Milan, Roma, Salerno
2019-04-26
Recruiting
European Institute of Oncology
Observational
120
Milan
2019-04-18
Active, closed
European Myeloma Network B.V.
Phase 2
401
Ancona, Bergamo, Bologna, Brescia, Catania, Genova, Milan, Novara
2019-04-16
Active, closed
AstraZeneca
Phase 3
810
Faenza, Florence, Milan, Naples, Roma, Verona
2019-04-16
Active, closed
Blueprint Medicines Corporation
Phase 2
251
Bologna, Milan, Salerno, Verona
2019-04-16
Active, closed
Università Vita-Salute San Raffaele
Not applicable
2,000
Cotignola, Catania, Lecce, Milan, Padua, Pisa, Potenza, Rome
2019-04-15
By invitation
IRCCS San Raffaele
Not applicable
49
Milan
2019-04-13
Recruiting
Eli Lilly and Company
Phase 3
190
Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
2019-04-05
Active, closed
Effects of Combined Aerobic and Cognitive Training in a Simultaneous or Sequential Paradigm on Cognition and Brain Functional Activity in Patients with AMCI
NCT06755164Mild Cognitive Impairment (MCI), AMCI - Amnestic Mild Cognitive Impairment, Neurodegenerative Dementia, Neurodegenerative Disease
IRCCS San Raffaele
Not applicable
55
Milan
2019-04-05
Active, closed
NASCITA Italian Birth Cohort Study
NCT03894566Social Determinants of Health, Health Knowledge, Attitudes, Practice, Development, Child, Mental Disorders
Mario Negri Institute for Pharmacological Research
Observational
5,000
Milan
2019-04-01
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Messina, Milan, Novara, Palermo, Roma, Bergamo, Florence, Pisa
2019-03-28
Active, closed
Eisai Inc.
Phase 3
1,906
Tricase, Cefalù, Genova, Milan, Monza, Naples, Perugia, Pisa
2019-03-27
Active, closed
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
DrugsZanzalintinib·Avelumab·Tecentriq·Atezolizumab
Exelixis
Phase 1
325
Milan, Pavia, Naples
2019-03-20
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
DrugsZolbetuximab·Nab-paclitaxel·Gemcitabine
Astellas Pharma Global Development, Inc.
Phase 2
393
Rozzano, Candiolo, Cremona, Lombardia, Milan, Toscana, Veneto
2019-03-15
Active, closed
Durvalumab and Tremelimumab for Pediatric Malignancies
NCT03837899Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies
DrugDurvalumab
AstraZeneca
Phase 1/2
50
Genova, Milan, Rome, Torino
2019-03-07
Active, closed
AstraZeneca
Phase 3
724
Florence, Genova, Milan, Orbassano, Padova, Pavia, Roma, Rozzano
2019-03-06
Active, closed
Azienda USL Reggio Emilia - IRCCS
Not applicable
10,156
Reggio Emilia, Milan, Verona
2019-03-01
Recruiting
Distribution of Lymph Node Metastases in Esophageal Carcinoma
NCT03222895Esophageal Neoplasms, Lymph Node Metastases
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
5,000
Milan, Verona
2019-03-01
Recruiting
Associazione Italiana per lo Studio del Pancreas
Observational
2,300
Milan
2019-02-28
Active, closed
Hoffmann-La Roche
Phase 3
1,000
Milan
2019-02-28
Recruiting
Hospices Civils de Lyon
Observational
3,500
Milan, Palermo, Parma
2019-02-25
Active, closed
Acerta Pharma BV
Phase 3
984
Meldola, Milan, Novara, Ravenna, Torino
2019-02-25
Active, closed
AbbVie
Phase 1
364
Milan
2019-02-21
Active, closed
NVT GmbH
Observational
346
Milan, Naples
2019-02-20
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Bologna, Meldola, Milan, Padova, Palermo, Rome
2019-02-08
Active, closed
Xenon Pharmaceuticals Inc.
Phase 2
325
Bologna, Catanzaro, Milan, Pavia, Pisa, Reggio Calabria, Roma
2019-01-30
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Faenza, Milan, Naples, Padova, Parma, Perugia, Pisa, Roma
2019-01-25
Active, closed
Fondazione Telethon
Phase 3
10
Milan
2019-01-21
Active, closed
Ancora Heart, Inc.
Not applicable
132
Milan, Cotignola
2019-01-15
Recruiting
RECORDATI GROUP
Observational
95
Florence, Milan, Monza, Naples, Padova, Turin
2019-01-15
Active, closed
AstraZeneca
Phase 2
367
Avellino, Florence, Milan, Orbassano, Padova, Parma, Perugia, Peschiera del Garda
2019-01-09
Recruiting
Istituto Auxologico Italiano
Observational
600
Milan
2019-01-08
Active, closed
AstraZeneca
Phase 3
1,407
Brescia, Lecce, Lecco, Milan, Mirano, Naples, Reggio Calabria, Reggio Emilia
2019-01-04
Active, closed
Celgene
Phase 3
363
Orbassano, Bologna, Florence, Meldola, Milan, Padova, Reggio Calabria, Roma
2019-01-02
Recruiting
Virginia Commonwealth University
Observational
700
Milan
2019-01-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Chieti, Milan, Turin, Bolzano, Florence, Arezzo, Bari, Genova
2018-12-24
Recruiting
Study of Individuals Affected With Hypoplasminogenemia
NCT03797495Plasminogen Deficiency
Indiana Hemophilia &Thrombosis Center, Inc.
Observational
100
Milan, Padua
2018-12-18
Active, closed
Travere Therapeutics, Inc.
Phase 3
406
Ranica, Milan, Bari, Catania, Catanzaro, Lecco, Modena, Pavia
2018-12-11
Recruiting
Vall d'Hebron Institute of Oncology
Phase 2
1,000
Milan
2018-12-10
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Ancona, Bergamo, Bologna, Misterbianco, Milan, Rozzano, Palermo, Aviano
2018-12-07
Recruiting
Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas
NCT04621201Diagnosed or Relapsed/Refractory Sarcomas
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Observational
120
Torino, Bologna, Florence, Genova, Milan, Pavia, Roma, Trieste
2018-12-06
Active, closed
AstraZeneca
Phase 3
825
Ancona, Bari, Bergamo, Florence, Milan, Monza, Padova, Roma
2018-12-06
Active, closed
AstraZeneca
Phase 3
724
Arezzo, Brescia, Milan, Pisa
2018-11-30
Active, closed
Safety and Efficacy of the ANTHEM™ CR Total Knee System
NCT03885622Non-inflammatory Degenerative Joint Disease
Smith & Nephew Pte Ltd
Observational
153
Milan
2018-11-23
Active, closed
AstraZeneca
Phase 3
1,063
Bari, Bologna, Florence, Milan, Naples, Orbassano, Pozzuoli, Verona
2018-11-16
Recruiting
Videocapsule Endoscopy in Lynch Syndrome
NCT05704010Lynch Syndrome, Lynch Syndrome I, Lynch Syndrome II, MLH1 Gene Mutation
San Raffaele University
Not applicable
100
Milan
2018-11-01
Active, closed
AstraZeneca
Phase 3
895
Milan, Naples, Orbassano, Pavia
2018-10-31
Active, closed
IRCCS San Raffaele
Observational
200
Lecco, Milan, Modena, Roma, Florence, Sassari, Verona
2018-10-30
Active, closed
AbbVie
Phase 3
265
Bologna, Turin, Rionero in Vulture, Ancona, Milan, Palermo, Terni
2018-10-22
Active, closed
AbbVie
Phase 2
270
Bologna, Meldola, Milan, Naples, Rome, Orbassano, Avellino, Parma
2018-10-10
Recruiting
Inhibrx Biosciences, Inc
Phase 1
411
Candiolo, Milan
2018-10-08
Active, closed
Exelixis
Phase 3
187
Viagrande, Catania, Meldola, Genova, Rozzano, Pisa, Torino, Milan
2018-10-05
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
DrugsPonatinib·Imatinib·Cytarabine·Vincristine
Takeda
Phase 3
245
Meldola, Genoa, Monza, Reggio Emilia, Mestre, Bologna, Lecce, Milan
2018-10-04
Recruiting
Istituto Auxologico Italiano
Not applicable
1,240
Milan
2018-10-01
Active, closed
AstraZeneca
Phase 3
730
Brescia, Milan, Orbassano, Parma, Roma, Rozzano, Terni
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,246
Arezzo, Milan, Naples, Orbassano, Parma, Pavia, Roma, Terni
2018-09-27
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Chieti, Bari, Trieste, Rome, Milan, Torrette - Ancona, Florence, Perugia
2018-09-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Meldola, Bari, Bergamo, Genova, Milan, Naples, Padova, Roma
2018-09-12
Active, closed
Fondazione Michelangelo
Phase 3
650
Bergamo, Brindisi, Faenza, Genova, Meldola, Milan, Modena, Negrar
2018-09-07
Active, closed
AbbVie
Phase 3
1,242
Genoa, Rozzano, Milan, Rho, Rome, Negrar, Bologna, Catania
2018-08-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Bologna, Rome, Milan, Monza, Rozzano, Aviano, Catania, Candiolo
2018-08-21
Active, closed
Hoffmann-La Roche
Phase 3
257
Naples, Rome, Milan, Orbassano, Perugia
2018-08-16
Active, closed
Gilead Sciences
Phase 2
502
Arezzo, Aviano, Cremona, Genoa, Meldola, Milan, Novara, Padova
2018-08-13
Active, closed
AbbVie
Phase 3
1,533
Rome, Rozzano, Ancona, Catania, Milan, Naples
2018-08-09
Recruiting
Sanofi
Phase 2
51
Genoa, Milan, Rome
2018-08-09
Recruiting
Celgene
Phase 2/3
1,541
Ancona, Bologna, Milan, Monza, Naples, Roma, Rome, Rozzano (MI)
2018-07-19
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Candiolo, Catania, Meldola (FC), Milan, Naples, Novara, Pavia, Pisa
2018-07-17
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
NCT03505320Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer, Pharmacokinetics of Oxaliplatin
DrugsZolbetuximab·Folinic acid·Fluorouracil·Leucovorin
Astellas Pharma Global Development, Inc.
Phase 2
143
Milan, Naples, Padova, Pisa
2018-06-29
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Alessandria, Bologna, Candiolo, Meldola, Milan
2018-06-26
Active, closed
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
NCT03485209Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer, Carcinoma, Squamous Cell of Head and Neck
DrugsTisotumab Vedotin·Tivdak·Keytruda·Cisplatin
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
350
Meldola (Fc), Ravenna, Meldola (FC), Rome, Brescia, Milan, Cattolica, Rimini
2018-06-25
Recruiting
Natural History of SMA
NCT05755451Muscular Atrophy, Spinal
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
1,200
Genova, Messina, Milan, Rome
2018-06-21
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Folinic acid·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Meldola, Monza, Vicenza, Ancona, Bergamo, Cremona, Milan, Modena
2018-06-21
Active, closed
NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma
NCT06972693Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma
European Institute of Oncology
Phase 4
323
Milan
2018-06-12
Active, closed
Exelixis
Phase 3
837
Tricase, Rozzano, Bologna, Brescia, Milan, Naples, Novara, Roma
2018-06-10
Active, closed
Genentech, Inc.
Phase 1
123
Milan
2018-06-06
Recruiting
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
2,000
Milan
2018-05-30
Active, closed
Canadian Cancer Trials Group
Phase 2
129
Milan
2018-05-28
Active, closed
Hoffmann-La Roche
Phase 3
927
Bari, Naples, Trieste, Rome, Genoa, Milan, Pavia, Pozzilli
2018-05-28
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
890
Rome, Milan, Naples
2018-05-21
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Milan, Roma
2018-05-14
Active, closed
Orchard Therapeutics
Phase 1/2
8
Milan
2018-05-11
Active, closed
Hoffmann-La Roche
Phase 1/2
211
Naples, Bologna, Bergamo, Milan
2018-05-08
Active, closed
Corcept Therapeutics
Phase 2
125
Ancona, Messina, Milan, Naples, Padova, Torino
2018-05-07
Active, closed
Centre Hospitalier Universitaire de Besancon
Not applicable
989
Milan, Monza
2018-05-03
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
Bologna, Florence, Genova, Milan, Monza, Naples, Pesaro, Rionero in Vulture PZ
2018-05-03
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
NCT03526835Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
DrugPetosemtamab
Merus B.V.
Phase 1/2
560
Milan
2018-05-02
Active, closed
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases
NCT03569241Prostate Cancer, Prostate Cancer Metastatic, Metastatic Cancer, Oligometastatic Cancer
University Hospital, Ghent
Phase 2
196
Milan, Naples, Pavia, Verona
2018-04-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Milano, Naples, Meldola, Rozzano, Milan, Monza, Orbassano, Brescia
2018-04-24
Active, closed
Cardiovalve Ltd.
Not applicable
30
Cotignola, Massa, Milan, Pisa
2018-04-23
Active, closed
Pyruvate Kinase Deficiency Global Longitudinal Registry
NCT03481738Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc.
Observational
500
Pescara, Naples, Genoa, Milan, Roma
2018-04-23
Active, closed
Bristol-Myers Squibb
Phase 3
545
Messina, Bologna, Florence, Meldola, Milan, Modena, Monserrato, Naples
2018-04-18
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Bologna, Cagliari, Cento, Messina, Milan, Padova, Roma, Rome
2018-04-13
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Turin, Bergamo, Milan, Naples, Padova, Siena
2018-04-11
Active, closed
AbbVie
Phase 3
1,336
Torrette, Genoa, Rozzano, Milan, Rho, Rome, Florence, Negrar
2018-04-09
By invitation
USWM CT, LLC
Phase 1
250
Milan
2018-04-09
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Bergamo, Candiolo, Carpi, Catania, Ferrara, Lecco, Livorno, Milan
2018-04-05
Active, closed
Y-mAbs Therapeutics
Phase 2
122
Genoa, Milan, Rome
2018-04-03
Active, closed
Development of Novel Clinical Endpoints in Intermediate AMD
NCT03349801Age Related Macular Degeneration (AMD)
Frank G. Holz
Observational
718
Milan, Rome
2018-03-26
Active, closed
AbbVie
Phase 3
747
Bologna, Rozzano, Milan, Rome, Negrar, Catania, Catanzaro, Genova
2018-03-21
Active, closed
Eli Lilly and Company
Phase 3
533
Milan, Roma
2018-03-14
Active, closed
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
NCT03458832Facioscapulohumeral Muscular Dystrophy
University of Kansas Medical Center
Observational
324
Milan
2018-03-05
Active, closed
Janssen Research & Development, LLC
Phase 2
136
Florence, Lecce, Milan, Naples, Province of Macerata
2018-03-02
Recruiting
Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms
NCT03981497Liver Cancer, Liver Metastasis Colon Cancer, Kidney Cancer, Renal Cell Carcinoma
Francesco De Cobelli
Observational
500
Milan
2018-02-28
Recruiting
Radiotherapy Treatments for Neoplasms of the Limbs
NCT06335251Bone Neoplasms, Bone Metastases
European Institute of Oncology
Observational
3,000
Milan
2018-02-22
Recruiting
Octapharma
Observational
200
Bari, Bologna, Castelfranco Veneto, Catania, Florence, Milan, Padova, Rome
2018-02-13
Active, closed
InSightec
Not applicable
92
Milan, Verona
2018-02-09
Recruiting
Duodenal Polyposis Classification in FAP
NCT07199127Duodenum Cancer, Familial Adenomatous Polyposis, Duodenal Polyposis, Ampulla of Vater Adenoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
300
Milan
2018-02-02
Active, closed
AMPLATZER PFO Occluder Post Approval Study
NCT03309332Stroke, Patent Foramen Ovale
Abbott Medical Devices
Not applicable
1,214
Milan
2018-01-31
Recruiting
Scientific Institute San Raffaele
Observational
1,000
Milan
2018-01-30
Recruiting
Scientific Institute San Raffaele
Observational
15,000
Milan
2018-01-30
Active, closed
Novartis Pharmaceuticals
Phase 1
105
Ancona, Milan, Rozzano
2018-01-29
Active, closed
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
NCT03386513Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm
DrugIMGN632
AbbVie
Phase 1/2
179
Bologna, Meldola, Milan, Perugia
2018-01-02
Recruiting
Evaluation of Risk of hEpatocellular Carcinoma
NCT06523179NASH, HCC, Genetic Predisposition
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Not applicable
500
Milan
2018-01-01
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
NCT03394365Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant
DrugTabelecleucel
Pierre Fabre Medicament
Phase 3
115
Milan, Pavia, Roma, Torino
2017-12-29
Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
NCT03328078Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma, Refractory Primary Central Nervous System Lymphoma
DrugsEmavusertib·Ibrutinib
Curis, Inc.
Phase 1/2
152
Cuneo, Florence, Meldola, Milan
2017-12-28
Recruiting
Registry for Patients With Lipodystrophy
NCT03553420Lipodystrophy Acquired, Lipodystrophy Congenital
University of Ulm
Observational
5,000
Bologna, Milan, Novara, Palermo, Pisa, Roma
2017-12-16
Recruiting
Castagna Antonella
Observational
300
Milan
2017-12-14
Active, closed
Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
NCT02984410Oropharyngeal Cancer, Supraglottic Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
112
Milan
2017-11-27
Active, closed
Alimentiv Inc.
Phase 4
334
San Donato Milanese, Milan, Roma, Castellana Grotte, Catania, Padova
2017-11-20
Recruiting
Non-invasive Ventilation Versus High Flow Oxygen
NCT03758508Pneumonia-associated Acute Hypoxemic Respiratory Failure
Niguarda Hospital
Not applicable
128
Milan
2017-11-01
Active, closed
Maastricht University Medical Center
Not applicable
250
Brescia, Milan, Rome
2017-11-01
Active, closed
BeiGene
Phase 3
590
Brescia, Meldola, Milan, Modena, Ravenna, Roma, Terni, Torino
2017-10-31
Active, closed
ViiV Healthcare
Phase 3
1,049
Brescia, Milan
2017-10-27
Active, closed
CUTISS AG
Phase 2
12
Milan, Naples
2017-10-25
Recruiting
Italfarmaco
Phase 2/3
206
Genova, Messina, Milan, Roma
2017-10-24
Active, closed
AstraZeneca
Phase 3
1,324
Benevento, Meldola, Milan, Naples, Perugia, Pisa, Roma, Rozzano
2017-10-11
Recruiting
Apollomics Inc.
Phase 2
497
Bologna, Meldola, Milan, Padova
2017-09-27
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Naples, Meldola, Aviano, Rome, Bergamo, Cremona, Milan, Monza
2017-09-22
Active, closed
Hoffmann-La Roche
Phase 3
382
Naples, Modena, Rome, Genoa, Milan, Monza, Novara, Orbassano
2017-09-20
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
DrugsCabozantinib·Tecentriq·Atezolizumab
Exelixis
Phase 1
914
Meldola, Rozzano, Milan, Naples, Pavia, Roma
2017-09-05
Recruiting
An Observational Study on Epithelioid Sarcoma
NCT03099681Epithelioid Sarcoma
Italian Sarcoma Group
Observational
100
Meldola, Milan, Rozzano, Palermo, Candiolo, Bologna, Padova, Prato
2017-08-22
Active, closed
Medtronic
Observational
1,092
Bologna, Castrovillari, Lecce, Milan, Taranto, Udine
2017-08-21
Active, closed
Breast Cancer Trials, Australia and New Zealand
Not applicable
1,167
Lecco, Milan
2017-08-21
Recruiting
Advenchen Laboratories, LLC
Phase 3
325
Milan, Palermo, Rome
2017-08-15
Active, closed
Murdoch Childrens Research Institute
Phase 3
450
Alessandria, Bologna, Florence, Genova, Milan, Pisa, Roma
2017-08-10
Active, closed
Savolitinib vs. Sunitinib in MET-driven PRCC.
NCT03091192Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Urologic Neoplasms
DrugsSavolitinib·Sunitinib
AstraZeneca
Phase 3
60
Arezzo, Meldola, Milan, Modena, Orbassano, Pavia, Roma
2017-07-25
Active, closed
Sarcoma Alliance for Research through Collaboration
Phase 2
126
Milan
2017-07-19
Active, closed
Eli Lilly and Company
Phase 3
5,637
Naples, Cona, Meldola, Monza, Milan, Rozzano, Rome, Terni
2017-07-12
Active, closed
Novartis Pharmaceuticals
Phase 2
29
Milan, Perugia
2017-07-04
Recruiting
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
100
Milan
2017-07-01
Recruiting
Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)
NCT03255928Thrombosis, Blood Coagulation Disorder, Platelet Thrombus, Platelet Dysfunction Due to Aspirin
Scientific Institute San Raffaele
Observational
60
Milan
2017-06-29
Active, closed
Ten Year Implant Survivorship of the ANTHEM™ PS Total Knee System
NCT03078543Arthroplasty, Replacement, Knee
Smith & Nephew, Inc.
Observational
148
Milan, Roma
2017-06-28
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Varese, Meldola, Milan, Pavia, Rimini, Torino
2017-06-26
Active, closed
MedSIR
Phase 2
377
Bologna, Brindisi, Cremona, Mantua, Milan, Monza, Piacenza
2017-06-26
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Bari, Bologna, Brescia, Florence, Forlì, Milan, Monza, Naples
2017-06-26
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
518
Bologna, Cona, Milan, Segrate, Udine
2017-06-21
By invitation
Tracking and Predicting How Brain Damage Spreads in Neurodegenerative Diseases
NCT07567664Neurodegenerative Disease, Behavioral Variant Frontotemporal Dementia (bvFTD), Primary Progressive Aphasia(PPA), Progressive Supranuclear Palsy(PSP)
IRCCS San Raffaele
Not applicable
645
Milan
2017-06-01
Recruiting
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
1,500
Milan
2017-05-31
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
DrugIbrutinib
Pharmacyclics Switzerland GmbH
Phase 4
297
Milan, Padova, Pavia, Torino, Udine
2017-05-22
By invitation
Fondazione Telethon
Observational
50
Milan
2017-05-05
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Alessandria, Bologna, Brescia, Cremona, Genova, Legnago, Milan, Naples
2017-05-03
Active, closed
Eli Lilly and Company
Phase 1/2
857
Milan
2017-05-02
Active, closed
Pfizer
Phase 3
296
Catania, Monza, Milan, Rozzano, Perugia, Pordenone, Parma, Roma
2017-04-27
Active, closed
Acerta Pharma BV
Phase 3
635
Bologna, Milan, Palermo, Parma, Pavia, Reggio Emilia, Rozzano, Turin
2017-04-05
Active, closed
AstraZeneca
Phase 3
987
Bergamo, Meldola, Milan, Palermo, Roma, Terni
2017-03-27
Active, closed
Bristol-Myers Squibb
Phase 3
1,314
Arezzo, Faenza, Forlì, Grosseto, Milan, Naples
2017-03-24
Recruiting
Italian Sarcoma Group
Not applicable
100
Milan, Bologna, Florence, Pavia, Pisa, Rome, Trento
2017-03-16
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
Milan, Palermo, Pordenone, Ravenna, Reggio Emilia, Roma, Terni
2017-03-07
Active, closed
Hoffmann-La Roche
Phase 1/2
940
Ravenna, Milan, Rozzano
2017-02-21
Active, closed
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
NCT03069469Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor
DrugVimseltinib
Deciphera Pharmaceuticals, LLC
Phase 1/2
120
Bologna, Milan, Rome
2017-02-16
Active, closed
LEADERS FREE II: BioFreedom™ Pivotal Study
NCT02843633Acute Coronary Syndrome, High Bleeding Risk
Biosensors Europe SA
Not applicable
1,203
Milan, Rome
2017-02-14
Active, closed
Persona Partial Knee Clinical Outcomes Study
NCT03034811Osteoarthritis, Avascular Necrosis, Traumatic Arthritis, Conditional Tibial Condyle or Plateau Fractures
Zimmer Biomet
Not applicable
757
Milan, Pavia
2017-02-08
Active, closed
Acerta Pharma BV
Phase 3
310
Aviano, Bergamo, Brescia, Florence, Genova, Meldola, Milan, Modena
2017-02-02
Active, closed
AbbVie
Phase 3
443
Lecce, Rome, Ancona, Bergamo, Bologna, Genova, Milan, Naples
2017-02-02
Active, closed
ITM Solucin GmbH
Phase 3
324
Meldola, Milan
2017-02-02
Active, closed
AbbVie
Phase 3
950
Bologna, Rozzano, Milan, Rho, Rome, Negrar, Palermo
2017-01-31
Recruiting
University College, London
Observational
2,500
Milan, Rome
2017-01-01
Active, closed
IRCCS San Raffaele
Observational
1,402
Milan, Padova, Verona
2017-01-01
Active, closed
Target PharmaSolutions, Inc.
Observational
10,000
Milan, Palermo, Rozzano, San Giovanni Rotondo
2016-12
Recruiting
Fosfomycin I.v. for Treatment of Severely Infected Patients
NCT02979951Bacterial Infections, Bone Diseases, Infectious, Osteomyelitis, Central Nervous System Bacterial Infections
Infectopharm Arzneimittel GmbH
Observational
1,000
Bari, Cuneo, Genova, Milan, Palermo, Rome, Torino, Udine
2016-12
Recruiting
Neurovascular Product Surveillance Registry
NCT02988128Intracranial Aneurysm, Stroke, Ischemic
Medtronic Neurovascular Clinical Affairs
Observational
4,000
Florence, Milan
2016-12
Active, closed
Eli Lilly and Company
Phase 1
100
Meldola, Milan
2016-11-14
Active, closed
Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience
NCT03077191Breast Cancer, Quality of Life, Radiotherapy; Adverse Effect, Dermatitis or Eczema, Survivorship
IRCCS San Raffaele
Observational
410
Milan
2016-11-01
Active, closed
ViiV Healthcare
Phase 3
618
Brescia, Milan
2016-10-28
Active, closed
ViiV Healthcare
Phase 3
631
Brescia, Milan, Monza MB, Roma
2016-10-27
Active, closed
Eisai Inc.
Phase 3
1,069
Faenza, Arezzo, Bologna, Genova, Lecce, Meldola, Milan, Modena
2016-10-13
Recruiting
Primary Tumor Research and Outcomes Network
NCT02790983Spinal Column Tumor
AO Innovation Translation Center
Observational
1,350
Bologna, Milan
2016-10
Recruiting
Observational Study on Endometrial Stromal Tumors
NCT02829437Endometrial Stromal Tumors
Italian Sarcoma Group
Observational
100
Meldola, Milan, Palermo, Aviano, Padova, Candiolo, Bologna, Florence
2016-10
Recruiting
IRCCS San Raffaele
Observational
15,000
Milan
2016-09-17
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Genova, Milan, Naples, Padova, Roma, Rozzano
2016-09-13
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
2,000
Milan, Padova, Verona
2016-09-01
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2
472
Genova, Milan, Torino
2016-08-03
Active, closed
Tesaro, Inc.
Phase 3
733
Lecce, Milan, Modena, Naples
2016-07-11
Active, closed
Philogen S.p.A.
Phase 3
214
Genova, Milan, Padova, Naples, Siena, Trieste, Turin
2016-07-01
Active, closed
AGO Study Group
Not applicable
797
Milan, Naples
2016-07
Active, closed
McGill University Health Centre/Research Institute of the McGill University Health Centre
Observational
530
Milan
2016-07
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Not applicable
50,000
Milan
2016-06-21
Active, closed
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer
NCT02716116Carcinoma, Non-Small-Cell Lung
DrugMobocertinib
Takeda
Phase 1/2
334
Milan, Parma
2016-06-16
Active, closed
Xcovery Holdings, Inc.
Phase 3
290
Milan, Perugia, Sondrio
2016-06
Recruiting
Heart Failure and Aortic Stenosis Transcriptome
NCT03268135Heart Failure, Aortic Stenosis
IRCCS Policlinico S. Donato
Observational
500
San Donato Milanese, Milan
2016-05-30
Recruiting
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
1,066
Milan
2016-05-11
Active, closed
Hoffmann-La Roche
Phase 1/2
69
Milan
2016-05-03
Recruiting
Boston Scientific Corporation
Observational
100
Milan
2016-05
Recruiting
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Not applicable
103
Milan
2016-04-26
Recruiting
UMC Utrecht
Phase 3
20,000
Brescia, Milan, Palermo, Reggio Emilia, Rimini
2016-04-11
Active, closed
Tesaro, Inc.
Phase 1
729
Milan, Modena, Naples, Roma, Verona
2016-03-07
Active, closed
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
NCT02710435Angina Pectoris, Angina Pectoris, Stable, Chronic Stable Angina
Shockwave Medical, Inc.
Observational
400
Milan, Seriate
2016-03
Recruiting
The Oxford Risk Factors And Non-Invasive Imaging Study
NCT05169333Cardiovascular Diseases, Cardiovascular Risk Factors
University of Oxford
Observational
250,000
Milan, Roma
2016-02-23
Active, closed
MedImmune LLC
Phase 1/2
383
Milan
2016-02-22
Recruiting
Metabolic Profile of Bone in Professional Athletes
NCT03386981Bone Disease, Metabolic, Physical Activity
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
200
Milan
2016-02-04
Active, closed
Physica CR and Physica PS Clinical Trial
NCT02766231Knee Osteoarthritis
Limacorporate S.p.a
Observational
157
Milan, Parma
2016-02
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
100
Milan
2016-01-13
Active, closed
Geron Corporation
Phase 2/3
289
Milan, Rozzano, Rionero in Vulture, Roma, Ancona, Bologna, Florence, Reggio Calabria
2016-01-12
Recruiting
Patient-reported Outcome Measures in Patient Underwent Total Hip and Knee Arthroplasty
NCT04960098Hip Osteoarthritis, Knee Osteoarthritis, Prosthesis Survival
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
5,816
Milan
2016-01-12
Active, closed
Bayer
Phase 1/2
154
Milan
2015-12-16
Active, closed
Novartis Pharmaceuticals
Phase 4
233
Bergamo, Bologna, Brescia, Meldola, Monza, Milan, Rozzano, Modena
2015-12-11
Active, closed
AbbVie
Phase 3
1,629
Rozzano, Turin, Milan, Verona
2015-12-01
Active, closed
Hoffmann-La Roche
Phase 2
534
Naples, Rome, Milan, Pisa, Perugia, Padova
2015-11-19
Recruiting
IRCCS San Raffaele
Phase 2
3
Rome, Milan
2015-11-06
Active, closed
AstraZeneca
Phase 3
1,126
Arezzo, Meldola, Milan, Naples, Orbassano, Pavia, Roma, San Giovanni Rotondo
2015-11-02
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Bologna, Monza, Milan, Rozzano, Roma
2015-11-02
Active, closed
AstraZeneca
Phase 3
682
Bari, Bergamo, Bologna, Cremona, Florence, Lucca, Meldola, Milan
2015-10-21
Active, closed
MedImmune LLC
Phase 2
433
Benevento, Milan, Roma
2015-10-19
Active, closed
Phase III Radium 223 mCRPC-PEACE III
NCT02194842Prostate Cancer
DrugsRa223·Enzalutamide
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
446
Carpi, Meldola, Milan
2015-10
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
420
Busto Arsizio, Meldola, Milan, Pavia
2015-08-06
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Ferrara, Florence, Genoa, Grosseto, Legnago, Meldola, Milan, Monza
2015-08
Active, closed
Acerta Pharma BV
Phase 3
533
Bologna, Cagliari, Cona, Florence, Meldola, Milan, Modena, Ravenna
2015-07-28
Active, closed
AstraZeneca
Phase 3
1,118
Genova, Meldola, Milan, San Giovanni Rotondo, Siena
2015-07-21
Active, closed
Taiho Oncology, Inc.
Phase 1/2
253
Bologna, Brescia, Milan, Monza
2015-07-14
Active, closed
Medtronic
Observational
3,100
Bari, Bologna, Brescia, Cotignola, Milan, Pisa, Roma
2015-07
Recruiting
The Medacta International SMS Post-Marketing Surveillance Study
NCT02748408Arthrosis, Traumatic Arthritis, Rheumatoid Polyarthritis, Congenital Hip Dysplasia
Medacta International SA
Observational
550
Milan
2015-07
Active, closed
Acerta Pharma BV
Phase 3
535
Alessandria, Aviano, Brescia, Florence, Meldola, Milan, Parma, Ravenna
2015-06-26
Recruiting
Centre Leon Berard
Phase 2/3
536
Milan
2015-06-02
Active, closed
Novartis Pharmaceuticals
Phase 1
57
Milan, Modena
2015-05-27
Active, closed
Eli Lilly and Company
Phase 3
545
Bari, Aviano, Orbassano, Bologna, Milan, Padova
2015-05-06
Recruiting
The European NAFLD Registry
NCT04442334NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver
Newcastle University
Observational
10,000
Ancona, Milan, Palermo, Rome, Turin
2015-05-01
Recruiting
IRCCS San Raffaele
Not applicable
180
Milan
2015-04-29
Recruiting
ALS/MND Natural History Study Data Repository
NCT05966038ALS, PLS, MND (Motor Neurone DIsease), Kennedy Disease
Massachusetts General Hospital
Observational
5,000
Milan
2015-04-01
Active, closed
Ischaemic PReconditioning In Non Cardiac surgEry
NCT02427867Myocardial Ischemia, Surgery
Università Vita-Salute San Raffaele
Not applicable
1,217
Rozzano, Busto Arsizio, Asti, Florence, Genova, Milan, Naples, Pisa
2015-04
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Ancona, Bari, Bologna, Brescia, San Giovanni Rotondo, Florence, Milan, Rozzano
2015-03-05
Active, closed
Acerta Pharma BV
Phase 2
124
Bologna, Meldola, Milan, Novara
2015-03-02
Active, closed
Exelixis
Phase 4
247
Catania, Roma, Siena, Pisa, Milan, Padua, Torino
2015-02-25
Recruiting
Protocol N. 2014 - Observational Study on the Quality of Life of Outpatients
NCT06193850Urologic Diseases, Male Infertility, Sexual Medicine
IRCCS San Raffaele
Observational
10,000
Milan
2015-02-24
Active, closed
ViiV Healthcare
Phase 3
371
Milan, Modena, Monza MB, Roma, Torino
2015-02-23
Active, closed
Hoffmann-La Roche
Phase 3
154
Bari, Bologna, Meldola, Reggio Emilia, Milan, Monza, Pisa
2015-02-02
By invitation
Registry of Patients With Hypophosphatasia
NCT02306720Hypophosphatasia (HPP)
Alexion Pharmaceuticals, Inc.
Observational
1,571
Sesto Fiorentino, Milan, Florence, Pisa, Rome, San Giovanni Rotondo
2015-01-20
Recruiting
IRCCS San Raffaele
Observational
20,000
Milan
2015-01-08
Active, closed
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
NCT02912949Solid Tumours Harboring NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, NRG1 Fusion
DrugBispecific
Partner Therapeutics, Inc.
Phase 2
250
Milan, Roma
2015-01
Active, closed
Acerta Pharma BV
Phase 1/2
113
Bologna, Milan, Palermo
2014-12-29
Recruiting
Protocollo N 2014 - Benign Prostatic Hyperplasia
NCT06182189Benign Prostatic Hyperplasia
IRCCS San Raffaele
Observational
8,000
Milan
2014-12-01
Recruiting
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
NCT02275286Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma, Liposarcoma
DrugTrabectedin
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2
199
Rozzano, Aviano, Bologna, Candiolo, Milan
2014-11
Active, closed
Acerta Pharma BV
Phase 2
107
Bologna, Milan, Novara
2014-09-11
Recruiting
Arrhythmias Detection in a Real World Population
NCT02275637Appropriate and Inappropriate Shock Therapy With ICD, Arrhythmias Detection
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
10,000
Bergamo, Bologna, Catania, Florence, Milan, Naples, Padua, Pavia
2014-09
Active, closed
AbbVie
Observational
1,446
Milan, Rome, Bologna, Messina, Naples, Palermo, Parma, Pescara
2014-08-28
Recruiting
Translational Cancer Observational Protocol
NCT06169436Upper Urinary Tract Urothelial Carcinoma
IRCCS San Raffaele
Observational
1,250
Milan
2014-07-17
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 2/3
360
Milan
2014-06
Recruiting
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
NCT02979119Factor VIII Deficiency, Factor IX Deficiency
PedNet Haemophilia Research Foundation
Observational
4,000
Florence, Genova, Milan
2014-06
Active, closed
PERIGON Pivotal Trial
NCT02088554Aortic Stenosis
Medtronic Cardiac Surgery
Not applicable
1,312
Milan
2014-05-12
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 3
128
Milan, Ravenna, Candiolo, Castelfranco Veneto, Terni, Busto Arsizio, Alessandria, Ascoli Piceno
2014-05
Active, closed
AstraZeneca
Phase 3
1,837
Bergamo, Bologna, Bolzano, Castellanza Varese, Lecce, Legnago, Milan, Modena
2014-04-22
Active, closed
University of Virginia
Observational
2,750
Bologna, Florence, Milan, Rome
2014-04
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 3
789
Padova, Pisa, Rome, Milan
2014-04
Recruiting
Jules Bordet Institute
Not applicable
1,000
Biella, Bolzano, Carpi, Genova, Legnago, Milan, Parma, Pavia
2014-04
Recruiting
Boston Scientific Corporation
Observational
1,500
Arcugnano, Ferrara, Mestre, Milan, Pavia, Rome, Udine
2014-03-04
Active, closed
Zimmer Trabecular Metal Total Ankle PMCF
NCT02038140Degenerative Arthritis, Rheumatoid Arthritis, Post Traumatic Arthritis
Zimmer Biomet
Not applicable
120
Milan
2014-03
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
252
Milan
2014-02-06
Active, closed
IRCCS San Raffaele
Observational
700
Milan
2014-02
Active, closed
ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia
NCT02029443Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Prolymphocytic Leukemia
DrugAcalabrutinib
Acerta Pharma BV
Phase 1/2
306
Milan
2014-01-30
Recruiting
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Observational
120
Rome, Milan, Padova
2014-01
Recruiting
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
NCT06167356Non Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Neoplasms, Non-Muscle Invasive Bladder Urothelial Carcinoma, Bladder Cancer
IRCCS San Raffaele
Observational
20,000
Milan
2013-11-27
Active, closed
AstraZeneca
Phase 3
510
Bari, Genova, Livorno, Milan, Naples, Orbassano, Parma, Perugia
2013-09-25
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Milan, Roma, Torino
2013-09-09
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Milan, Modena, Naples, Padova, Roma
2013-09-03
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Bari, Catania, Milan, Naples, Padova, Roma
2013-08-26
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Bari, Montichiari, Catania, Milan, Cefalù, Roma, Gallarate
2013-07-26
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
200
Milan
2013-06
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Bari, Naples, Udine, Genoa, Bergamo, Milan, Turin, Florence
2013-05-30
Active, closed
MedImmune LLC
Phase 2
571
Alessandria, Aviano, Bergamo, Bologna, Candiolo, Genova, Meldola, Milan
2013-05-17
Active, closed
AbbVie
Observational
8,250
Bologna, Florence, San Giovanni Rotondo, Genoa, Rozzano, Milan, Naples, Rome
2013-04-29
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Bari, Florence, Genova, Milan, Roma, Torino
2013-03-18
Active, closed
Italfarmaco
Phase 2
90
Bari, Bergamo, Florence, Milan, Pescara, Pavia, Reggio Calabria, Vicenza
2013-03
Recruiting
Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy
NCT06170177Muscle-Invasive Bladder Carcinoma, Muscle Invasive Bladder Urothelial Carcinoma, Bladder Cancer TNM Staging, Bladder Cancer Stage IIa
IRCCS San Raffaele
Observational
4,000
Milan
2013-02-04
Recruiting
Scientific Institute San Raffaele
Observational
20
Milan
2013-01-01
Active, closed
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Not applicable
4,119
Milan
2013-01
Active, closed
University College, London
Phase 3
500
Milan
2012-11-08
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Milan, Bari, Bologna, Genoa, Naples, Rome
2012-07
Recruiting
TIRCON International NBIA Registry
NCT05522374Neurodegeneration With Brain Iron Accumulation (NBIA), Pantothenate Kinase-associated Neurodegeneration (PKAN), Beta-Propeller Protein-Associated Neurodegeneration (BPAN), Mitochondrial Membrane Protein Associated Neurodegeneration (MPAN)
LMU Klinikum
Observational
2,000
Milan
2012-06-14
Active, closed
Bristol-Myers Squibb
Observational
2,555
Pesaro, Ancona, Cagliari, Florence, Lecce, Messina, Milan, Naples
2012-06-13
Active, closed
A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee
NCT01542580Osteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis, Post Traumatic Deformity
Zimmer Biomet
Observational
255
Milan, Pisa
2012-03
Recruiting
Improving Non-invasive Ventilation
NCT01571986Acute Respiratory Failure
Università Vita-Salute San Raffaele
Observational
750
Milan
2012-02
Active, closed
Sentinel Node Vs Observation After Axillary Ultra-souND
NCT02167490Early Stage Breast Carcinoma
European Institute of Oncology
Not applicable
1,560
Bolzano, Brescia, Cagliari, Castellanza, Como, Mantua, Milan, Naples
2012-01
Active, closed
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
NCT01385176Heart Failure, Congestive Heart Failure
Boston Scientific Corporation
Not applicable
118
Milan, Naples, Pavia
2011-09-21
Recruiting
Ospedale San Raffaele
Not applicable
142
Rozzano, Milan
2011-06-08
Active, closed
Fondazione del Piemonte per l'Oncologia
Observational
2,500
Aosta, Bologna, Candiolo, Genova, Milan, Orbassano, Padova, Pisa
2011-03-30
Recruiting
International (Pediatric) Peritoneal Biobank
NCT01893710Kidney Failure, Chronic, Peritoneal Dialysis Complication, Transplantation, Healthy
Heidelberg University
Observational
500
Genova, Milan, Padova
2011-02-01
Active, closed
W.L.Gore & Associates
Observational
4,600
Milan
2010-12
Recruiting
IRCCS San Raffaele
Observational
15,000
Milan
2010-10-07
Recruiting
Azienda Ospedaliero-Universitaria di Parma
Observational
1,000
Milan, Palermo, Parma, Urbino, Bologna, Carrara, Genova, Naples
2010-09
Recruiting
IRCCS San Raffaele
Observational
3,000
Milan
2010-08-24
Recruiting
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
NCT01193088Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
University of Iowa
Observational
1,050
Milan
2010-05
Recruiting
Michael Shy
Observational
5,000
Milan
2010-04-01
Active, closed
AstraZeneca
Phase 2
162
Genova, Milan, Monza, Torino
2010-02-04
Recruiting
Kidney Cancer Observational Protocol
NCT06147349Renal Cancer
IRCCS San Raffaele
Observational
2,500
Milan
2010-01-27
Recruiting
Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)
NCT06911099Atrial Functional Mitral Regurgitation, Mitral Insufficiency
University Hospital of Cologne
Observational
1,000
Brescia, Milan, Pisa
2010-01-01
Active, closed
Minimal SN Tumor Burden
NCT01942603Cutaneous Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Observational
296
Milan, Naples, Padova
2009-07
Recruiting
Global Registry and Natural History Study for Mitochondrial Disorders
NCT05554835Mitochondrial Diseases, Kearns-Sayre Syndrome, MIDD, SANDO
LMU Klinikum
Observational
6,000
Bologna, Brescia, Cagliari, Florence, Genova, Messina, Milan, Pisa
2009-02-01
Active, closed
Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up
NCT01357772Carcinoma, Intraductal, Noninfiltrating, Recurrence, Local Neoplasm, Breast Neoplasms, Atypical Hyperplasia
DrugTamoxifen
Andrea DeCensi
Phase 3
500
Tortona, Meldola, Carpi, Bari, Catanzaro, Genoa, Milan, Modena
2008-11-12
Active, closed
Genentech, Inc.
Phase 2
378
Potenza, Catanzaro, Naples, Meldola, Parma, Aviano (PN), Udine, Milan
2008-10-16
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
Bologna, Milan, Torino
2007-12
Recruiting
Pompe Pregnancy Sub-Registry
NCT00567073Glycogen Storage Disease Type II (GSD-II), Pompe Disease (Late-onset), Glycogenesis 2 Acid Maltase Deficiency
Genzyme, a Sanofi Company
Observational
20
Florence, Milan, Padua, Rome, Brescia, Cagliari, Genova, Messina
2007-06-18
Recruiting
Genetics in the Progression of Nephropathies
NCT06416761AKI, CKD, Ckd-Mbd, CKD (Chronic Kidney Disease) Stage 5D
Ospedale San Raffaele
Observational
10,000
Milan
2006-05-19
Recruiting
University Hospital, Gasthuisberg
Observational
5,000
Milan, Torino
2005-08
Recruiting
The EUROSCA Natural History Study
NCT02440763Spinocerebellar Ataxia
Ataxia Study Group
Observational
400
Milan, Naples
2005-07
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Gussago, Cona, Florence, Milan, Padua, Rome, Brescia, Cagliari
2004-09-15
Recruiting
TrialNet Pathway to Prevention of T1D
NCT00097292Diabetes Mellitus, Type 1
University of South Florida
Observational
75,000
Milan
2004-02-01
Recruiting
Establishment of a Tumor Bank for Blood Samples
NCT01763125Ovarian Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Neoplasms of the Female Genitalia
Medical University of Vienna
Observational
10,000
Milan
2003-11
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Florence, Milan, Baggiovara, Monza, Padua, Rome, Bassano del Grappa, Bologna
2001-07-31
By invitation
Copenhagen University Hospital, Rigshospitalet
Observational
23,000
Bergamo, Milan, Modena, Naples, Rome
1994-01
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Florence, Milan, Baggiovara, Monza, Rome, Sassari, Catania, Genova
1991-04-01
Recruiting
Medtronic
Observational
20,000
Ancona, Bari, Bologna, Brescia, Castrovillari, Cotignola, Lecce, Milan
1983-01
Rows per page Showing 2501–2846 of 2846
Previous 4 5 6
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/milan?page=6

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2,846 of those studies with a site in Milan.

How many clinical trials are recruiting in Milan?

1,595 of the 2,846 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 145 have not yet opened recruitment, 1,033 are active but closed to new participants, and 73 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.